BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 286576)

  • 1. Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.
    Murray RM; Oon MC; Rodnight R; Birley JL; Smith A
    Arch Gen Psychiatry; 1979 Jun; 36(6):644-9. PubMed ID: 286576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary dimethyltryptamine and psychiatric symptomatology and classification.
    Rodnight R; Murray RM; Oon MC; Brockington IF; Nicholls P; Birley JL
    Psychol Med; 1976 Nov; 6(4):649-57. PubMed ID: 1070024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.
    Checkley SA; Murray RM; Oon MC; Rodnight R; Birley JL
    Br J Psychiatry; 1980 Sep; 137():236-9. PubMed ID: 6777009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Urinary dimethyltryptamine in psychiatric patients.
    Oon MC; Murray RH; Brockington IF; Rodnight R; Birley JL
    Lancet; 1975 Dec; 2(7945):1146-7. PubMed ID: 53629
    [No Abstract]   [Full Text] [Related]  

  • 5. The excretion of dimethyltryptamine in psychiatric patients.
    Murray RM; Oon MC
    Proc R Soc Med; 1976 Nov; 69(11):831-2. PubMed ID: 1070023
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary excretion of dimethyltryptamine in liver disease.
    Checkley SA; Oon MC; Rodnight R; Murphy MP; Williams RS; Birley JL
    Am J Psychiatry; 1979 Apr; 136(4A):439-41. PubMed ID: 284722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.
    Oon MC; Murray RM; Rodnight R; Murphy MP; Birley JL
    Psychopharmacology (Berl); 1977 Oct; 54(2):171-5. PubMed ID: 22091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tryptaminuria and urinary 5-H.I.A.A. in neuropsychiatry (preliminary note)].
    Bourgeois M; Henry P
    Ann Med Psychol (Paris); 1967 Oct; 125(3):Suppl 2:440-6. PubMed ID: 6081829
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
    Huszka L; Zabek DH; Doust JW
    Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
    Vitale AA; Pomilio AB; Cañellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
    J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
    Forsström T; Tuominen J; Karkkäinen J
    Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat.
    Sitaram BR; Lockett L; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 Jul; 36(13):2235-7. PubMed ID: 3475068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
    Matsumoto H; Pietruszewska I
    Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological heterogeneity in schizophrenic patients.
    Buchsbaum MS; Davis GC
    Am J Psychiatry; 1979 Dec; 136(12):1618. PubMed ID: 292318
    [No Abstract]   [Full Text] [Related]  

  • 16. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 18. On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
    Grammenos D; Barker SA
    J Neural Transm (Vienna); 2015 Jun; 122(6):733-9. PubMed ID: 25362533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of N,N-dimethyltryptamine by urine].
    Spatz N; Spatz H; Mesones Arroyo HL; Rosan T; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1993 Sep; 39(3):212-6. PubMed ID: 7905222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
    Brown T; Shao W; Ayub S; Chong D; Cornelius C
    J Psychoactive Drugs; 2017; 49(4):294-296. PubMed ID: 28686543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.